Hepatitis C Therapy - Zacks.com Announces That Vivian Lewis Highlights the Following Stocks: ICICI, Companhia Vale do Rio Doce and Teva

Zacks.com Announces That Vivian Lewis Highlights the Following Stocks: ICICI, Companhia Vale do Rio Doce and Teva
[Press Release] Business Wire via Yahoo! Finance - Jan 17 3:00 AM
CHICAGO----Jan. 17, 2006--Vivian Lewis expects the EU countries to post significant U.S.-style growth this year. Learn about ICICI , Companhia Vale do Rio Doce and Teva Pharmaceutical Industries .Save to My Web

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program
[Press Release] PR Newswire via Yahoo! Finance - Jan 18 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical-stage product candidates for viral diseases and cancer, today announced that it has accelerated its clinical program for Tarvacin Anti-Viral for the treatment of chronic hepatitis C virus infection .Save to My Web

Hepatitis C Patients Taxing Medical System
MedicineNet.com - Jan 27 4:21 AM
Title: Hepatitis C Patients Taxing Medical System Category: Health News Created: 12/31/2005 1:59:00 AM Last Editorial Review: 12/31/2005 1:58:37 AMSave to My Web